Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 4c

May 3, 2023 7:18 AM EDT

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.87), $0.04 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $131 million versus the consensus estimate of $128.07 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities